3,6-Dibromopyridazine(CAS: 17973-86-3)

3,6-Dibromopyridazine (CAS: 17973-86-3) falls under the scope of the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for potential skin and eye irritation. It is also subject to the REACH regulation in the European Union, which requires registration of substances above 1 tonne per year. In the United States, it is regulated by the FDA and EPA under the Toxic Substances Control Act (TSCA) and the Emergency Planning and Community Right-to-Know Act (EPCRA).

While 3,6-Dibromopyridazine (CAS: 17973-86-3) is a specific compound, alternatives such as 3-bromopyridazine or 6-bromopyridazine can be used as substitutes in certain synthesis processes. These alternatives offer similar functional groups for diversifying the molecular structure.

The market for 3,6-Dibromopyridazine (CAS: 17973-86-3) is driven by its use in pharmaceutical and agrochemical applications, particularly in the development of herbicides and antibiotics. Recent research trends focus on its potential in antifungal and anticancer drug discovery. Market trends suggest increasing demand due to its unique chemical properties and applications.

Waste containing 3,6-Dibromopyridazine (CAS: 17973-86-3) should be collected in appropriate containers, ensuring proper labeling. Incineration is a common method for disposal, but professional waste disposal services are recommended to ensure compliance with environmental regulations. Environmental protection measures include minimizing exposure to water sources and using protective gear during handling and disposal.